Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decidual Stromal Cells for Prevention of Graft-versus-Host Disease
IRCT20240513061768N2Phase 2Recruiting
- Sponsor
- Taskin Bioregeneration
- Start
- Jan 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of decidua stroma cells in graft-versus-host disease (GVHD), sponsored by Taskin Bioregeneration. Started Jan 2026; status: recruiting.
02
Drugs
decidua stroma cells
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on IRCT20240513061768N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240513061768N2.